Zura Bio Limited
ZURA
$1.37
$0.1411.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 34.19% | -100.43% | -33.33% | 8.57% | -2.45% |
| Total Depreciation and Amortization | 66.67% | 200.00% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.44% | 238.73% | 23.40% | 112.05% | -42.60% |
| Change in Net Operating Assets | -100.98% | 13,268.42% | 108.37% | -107.54% | -7.16% |
| Cash from Operations | -91.47% | 14.57% | -32.82% | -22.92% | -57.64% |
| Capital Expenditure | -246.15% | -30.00% | -42.86% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -- | 100.00% |
| Cash from Investing | -246.15% | -30.00% | 99.80% | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -90.81% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -84.83% | -100.68% | -- | -- | 100.00% |
| Cash from Financing | -115.69% | -94.83% | -- | -- | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5,180.63% | -100.23% | 1,087.35% | -146.46% | 54.68% |